Web Analytics

3 Latest Announced Rounds

  • $40,000,000
    Series B

    5 Investors

    Financial Services
    Jun 5th, 2026
  • $8,000,000
    Series A

    1 Investors

    Biotechnology Research
    Jun 5th, 2026
  • $32,500,000
    Series A

    3 Investors

    Biotechnology
    Jun 5th, 2026
$1,098.56M Raised in 36 Funding Rounds in the past 7 Days - View All

Funding Round Profile

BioLoomics, Inc.

start up
United States - Boulder, CO
  • 20/09/2023
  • Seed
  • $8,700,000

BioLoomics is a preclinical stage biotechnology company leveraging directed evolution of antibodies in human cells to create target degrading antibodies. Our proprietary tech combines single-cell bioassay engineering, robotics, and ML.
#synbio #directedevolution #antibodies


Related People

Doug ChapnickFounder

Doug Chapnick United States - Boulder, Colorado

Entrepreneur and biotechnology developer.